These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
274 related items for PubMed ID: 21387549
1. The use of sodium polystyrene sulfonate in the inpatient management of hyperkalemia. Kessler C, Ng J, Valdez K, Xie H, Geiger B. J Hosp Med; 2011 Mar; 6(3):136-40. PubMed ID: 21387549 [Abstract] [Full Text] [Related]
2. Evaluation of Sodium Polystyrene Sulfonate Dosing Strategies in the Inpatient Management of Hyperkalemia. Mistry M, Shea A, Giguère P, Nguyen ML. Ann Pharmacother; 2016 Jun; 50(6):455-62. PubMed ID: 27048188 [Abstract] [Full Text] [Related]
3. Evaluation of the tolerability and efficacy of sodium polystyrene sulfonate for long-term management of hyperkalemia in patients with chronic kidney disease. Georgianos PI, Liampas I, Kyriakou A, Vaios V, Raptis V, Savvidis N, Sioulis A, Liakopoulos V, Balaskas EV, Zebekakis PE. Int Urol Nephrol; 2017 Dec; 49(12):2217-2221. PubMed ID: 29027620 [Abstract] [Full Text] [Related]
4. Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD. Lepage L, Dufour AC, Doiron J, Handfield K, Desforges K, Bell R, Vallée M, Savoie M, Perreault S, Laurin LP, Pichette V, Lafrance JP. Clin J Am Soc Nephrol; 2015 Dec 07; 10(12):2136-42. PubMed ID: 26576619 [Abstract] [Full Text] [Related]
5. Treatment of pediatric hyperkalemia with sodium polystyrene sulfonate. Lee J, Moffett BS. Pediatr Nephrol; 2016 Nov 07; 31(11):2113-7. PubMed ID: 27215929 [Abstract] [Full Text] [Related]
6. Sodium polystyrene sulfonate for the treatment of acute hyperkalemia: a retrospective study. Hagan AE, Farrington CA, Wall GC, Belz MM. Clin Nephrol; 2016 Jan 07; 85(1):38-43. PubMed ID: 26587776 [Abstract] [Full Text] [Related]
7. Evaluation of Appropriate Sodium Polystyrene Sulfonate Use With a Hyperkalemia Order Set: A Pilot Study. Mueller ZT, Crannage AJ. J Pharm Pract; 2019 Oct 07; 32(5):493-498. PubMed ID: 29642732 [Abstract] [Full Text] [Related]
8. Pretreatment of formula or expressed breast milk with sodium polystyrene sulfonate (Kayexalate(®)) as a treatment for hyperkalemia in infants with acute or chronic renal insufficiency. Thompson K, Flynn J, Okamura D, Zhou L. J Ren Nutr; 2013 Sep 07; 23(5):333-9. PubMed ID: 23707305 [Abstract] [Full Text] [Related]
9. Compared effects of calcium and sodium polystyrene sulfonate on mineral and bone metabolism and volume overload in pre-dialysis patients with hyperkalemia. Nakayama Y, Ueda K, Yamagishi SI, Sugiyama M, Yoshida C, Kurokawa Y, Nakamura N, Moriyama T, Kodama G, Minezaki T, Ito S, Nagata A, Taguchi K, Yano J, Kaida Y, Shibatomi K, Fukami K. Clin Exp Nephrol; 2018 Feb 07; 22(1):35-44. PubMed ID: 28421299 [Abstract] [Full Text] [Related]
10. Effectiveness of Sodium Polystyrene Sulfonate for Short-Term Treatment of Hyperkalemia. Batterink J, Lin J, Au-Yeung SH, Cessford T. Can J Hosp Pharm; 2015 Feb 07; 68(4):296-303. PubMed ID: 26327703 [Abstract] [Full Text] [Related]
11. Damned if you do, damned if you don't: potassium binding resins in hyperkalemia. Watson M, Abbott KC, Yuan CM. Clin J Am Soc Nephrol; 2010 Oct 07; 5(10):1723-6. PubMed ID: 20798253 [Abstract] [Full Text] [Related]
12. Comparison of effectiveness and safety of sodium polystyrene sulfonate and sodium zirconium cyclosilicate for treatment of hyperkalemia in hospitalized patients. Sullivan E, Ruegger M, Dunne I, Sutaria N, Towers WF. Am J Health Syst Pharm; 2023 Sep 07; 80(18):1238-1246. PubMed ID: 37335862 [Abstract] [Full Text] [Related]
13. Management of hyperkalemia in hospitalized patients. Fordjour KN, Walton T, Doran JJ. Am J Med Sci; 2014 Feb 07; 347(2):93-100. PubMed ID: 23255245 [Abstract] [Full Text] [Related]
14. Association of prescription of oral sodium polystyrene sulfonate with sorbitol in an inpatient setting with colonic necrosis: a retrospective cohort study. Watson MA, Baker TP, Nguyen A, Sebastianelli ME, Stewart HL, Oliver DK, Abbott KC, Yuan CM. Am J Kidney Dis; 2012 Sep 07; 60(3):409-16. PubMed ID: 22683337 [Abstract] [Full Text] [Related]
15. Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients. Yu MY, Yeo JH, Park JS, Lee CH, Kim GH. PLoS One; 2017 Sep 07; 12(3):e0173542. PubMed ID: 28328954 [Abstract] [Full Text] [Related]
16. Polysulfonate Resins in Hyperkalemia: A Systematic Review. Wong SWS, Zhang G, Norman P, Welihinda H, Wijeratne DT. Can J Kidney Health Dis; 2020 Sep 07; 7():2054358120965838. PubMed ID: 33240515 [Abstract] [Full Text] [Related]
17. Single Dose of Sodium Zirconium Cyclosilicate Versus Sodium Polystyrene Sulfonate in Hospitalized Patients With Hyperkalemia. Yoo N, Song YB, Dubinsky I, Altshuler J. Ann Pharmacother; 2023 Sep 07; 57(9):1044-1052. PubMed ID: 36637028 [Abstract] [Full Text] [Related]
18. Sodium polystyrene sulfonate versus sodium zirconium cyclosilicate for the treatment of hyperkalemia in the emergency department. Hasara S, Dubey J, Amatea J, Finnigan N. Am J Emerg Med; 2023 Mar 07; 65():59-64. PubMed ID: 36586223 [Abstract] [Full Text] [Related]
19. Serum potassium response to single-dose sodium zirconium cyclosilicate for the treatment of asymptomatic hyperkalemia in hospitalized patients. Lewis H, Stamper B, Yungkurth AC. Pharmacotherapy; 2024 Jan 07; 44(1):13-21. PubMed ID: 37475499 [Abstract] [Full Text] [Related]
20. Dose-response to a jelly preparation of calcium polystyrene sulfonate in patients with hyperkalemia--changes in serum potassium levels with or without a RAAS inhibitor. Tomino Y, Yamazaki T, Shou I, Tsuge T, Satake K, Takeda Y, Ohtani A, Nishitani T, Kurusu A, Hamada C, Horikoshi S, Maeda K, Tanaka Y, Fukuda H, Wakabayashi M, Seto T. Clin Nephrol; 2007 Dec 07; 68(6):379-85. PubMed ID: 18184520 [Abstract] [Full Text] [Related] Page: [Next] [New Search]